預防保健市場：按服務類型、疾病領域、年齡層、服務提供方式、最終用戶和地區分類

預計到2026年，預防醫學市場規模將達到4.636億美元，到2033年將達到6.743億美元。預計從2026年到2033年，該市場將以5.5%的複合年成長率成長。

近年來，全球預防醫學市場經歷了顯著成長，這主要得益於人們對疾病預防和早期檢測重要性的認知不斷提高。預防醫學著重於採取積極主動的措施來預防疾病爆發，並促進整體健康和福祉。這種方法涵蓋了廣泛的策略，包括健康檢查、疫苗接種、生活方式調整和風險評估。市場成長歸因於多種因素，包括慢性病盛行率上升、人口老化以及人們對降低醫療成本日益成長的關注。此外，診斷工具的技術進步和創新預防療法的開發也進一步推動了市場擴張。隨著世界各國政府和醫療機構認知到預防醫學的長期益處，預計未來幾年對預防醫學解決方案的需求將繼續保持上升趨勢。

市場動態：

全球預防醫學市場受多種關鍵市場促進因素、限制因素和機會的影響。其中一個主要促進因素是心血管疾病、糖尿病和癌症等慢性疾病的日益普遍。這些疾病負擔的加重促使人們更加重視早期發現和預防，從而推動了對預防性醫療保健解決方案的需求。此外，全球人口老化也進一步加速了市場成長，因為老年人更容易患慢性疾病，需要定期預防保健。然而，該市場也面臨一些限制因素，例如預防性醫療保健技術高成本，以及某些地區對預防保健益處的認知不足。

此外，部分國家對預防性服務的保險報銷限制可能會阻礙市場成長。儘管有這些挑戰，該市場仍蘊藏著巨大的成長和創新機會。穿戴式裝置和遠端醫療等數位健康技術的日益普及，為遠端監測和個人化預防保健開闢了新的途徑。此外，基因檢測和生物標記分析等先進診斷工具的開發，使得風險評估更加精準，預防干涉措施也更有針對性。隨著各國政府和醫療機構將預防醫學置於優先地位，並持續增加對預防醫學計畫的投入，預計未來幾年該市場將實現顯著成長。

本研究的主要特點：

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數對全球預防醫學市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球預防醫學市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過分析全球預防醫學市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球預防性醫療保健市場：依服務類型分類，2021-2033年

• 篩檢和早期檢測
• 慈善與免疫接種
• 預防性藥物治療
• 健康與生活方式干涉
• 數位健康和​​遠端監測服務

第5章 全球預防保健市場：依疾病分類，2021-2033年

• 心血管疾病
• 癌症
• 糖尿病
• 感染疾病
• 呼吸系統疾病
• 心理健康
• 神經病變
• 骨質疏鬆症
• 其他

第6章 全球預防保健市場：依年齡層別分類，2021-2033年

• 兒童
• 成人
• 老年人

第7章 全球預防保健市場：依服務提供方式分類，2021-2033年

• 現場/親自送貨
• 遠端/虛擬交付

第8章 全球預防保健市場：依最終用戶分類，2021-2033年

• 醫院和診所
• 診斷中心
• 政府機構
• 私人醫療保健機構
• 雇主
• 個人（自我護理）

第9章 全球預防保健市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第10章 競爭格局

• Abbott Laboratories
• AstraZeneca
• Bayer AG
• Becton, Dickinson and Company（BD）
• bioMerieux
• Bristol Myers Squibb
• Danaher Corporation
• GlaxoSmithKline（GSK）
• Merck & Co Inc
• Novartis
• Pfizer
• Roche Holding AG
• Sanofi
• Siemens Healthineers
• Quest Diagnostics

第11章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第12章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Preventive Medicine Market is estimated to be valued at USD 463.6 Mn in 2026 and is expected to reach USD 674.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.

The global preventive medicine market has witnessed significant growth in recent years, driven by the increasing awareness about the importance of disease prevention and early detection. Preventive medicine focuses on the proactive measures taken to prevent the occurrence of diseases and promote overall health and well-being. This approach encompasses a wide range of strategies, including health screenings, vaccinations, lifestyle modifications, and risk assessment. The market's growth can be attributed to several factors, such as the rising prevalence of chronic diseases, the increasing elderly population, and the growing emphasis on reducing healthcare costs. Additionally, technological advancements in diagnostic tools and the development of innovative preventive therapies have further fueled the market's expansion. As governments and healthcare organizations worldwide recognize the long-term benefits of preventive care, the demand for preventive medicine solutions is expected to continue its upward trajectory in the coming years.

Market Dynamic:

The global preventive medicine market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and cancer. The rising burden of these diseases has led to a greater emphasis on early detection and prevention, fueling the demand for preventive medicine solutions. Moreover, the growing elderly population worldwide has further accelerated the market's growth, as older individuals are more susceptible to chronic conditions and require regular preventive care. However, the market also faces certain restraints, such as the high costs associated with preventive medicine technologies and the lack of awareness about the benefits of preventive care in some regions.

Additionally, limited reimbursement policies for preventive services in certain countries may hinder the market's growth. Despite these challenges, the market presents significant opportunities for growth and innovation. The increasing adoption of digital health technologies, such as wearable devices and telemedicine, has opened up new avenues for remote monitoring and personalized preventive care. Furthermore, the development of advanced diagnostic tools, such as genetic testing and biomarker analysis, has enabled more accurate risk assessment and targeted preventive interventions. As governments and healthcare organizations continue to prioritize preventive care and allocate resources towards preventive medicine initiatives, the market is poised for substantial growth in the coming years.

Key Features of the Study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global preventive medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, AstraZeneca, Bayer AG, Becton, Dickinson and Company (BD), bioMerieux, Bristol Myers Squibb, Danaher Corporation, GlaxoSmithKline (GSK), Merck & Co Inc, Novartis, Pfizer, Roche Holding AG, Sanofi, Siemens Healthineers, and Quest Diagnostics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global preventive medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive medicine market

Market Segmentation

• Service Type Insights (Revenue, USD Mn, 2021 - 2033)
• Screening & Early Detection
• Vaccination & Immunizatio
• Preventive Drug Therapies
• Wellness & Lifestyle Interventions
• Digital Health & Remote Monitoring Services
• Disease Area Insights (Revenue, USD Mn, 2021 - 2033)
• Cardiovascular Diseases
• Cancer
• Diabetes
• Infectious Diseases
• Respiratory Diseases
• Mental Health
• Neurological Disorders
• Osteoporosis
• Others
• Age Group Insights (Revenue, USD Mn, 2021 - 2033)
• Pediatric
• Adult
• Geriatric
• Mode of Delivery Insights (Revenue, USD Mn, 2021 - 2033)
• On-site/In-Person Delivery
• Remote/Virtual Delivery
• End User Insights (Revenue, USD Mn, 2021 - 2033)
• Hospitals & Clinics
• Diagnostic Centers
• Government Organizations
• Private Healthcare Providers
• Employers
• Individuals (Self-Care)
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Abbott Laboratories
• AstraZeneca
• Bayer AG
• Becton, Dickinson and Company (BD)
• bioMerieux
• Bristol Myers Squibb
• Danaher Corporation
• GlaxoSmithKline (GSK)
• Merck & Co Inc
• Novartis
• Pfizer
• Roche Holding AG
• Sanofi
• Siemens Healthineers
• Quest Diagnostics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Preventive Medicine Market, By Service Type
  • Global Preventive Medicine Market, By Disease Area
  • Global Preventive Medicine Market, By Age Group
  • Global Preventive Medicine Market, By Mode of Delivery
  • Global Preventive Medicine Market, By End User
  • Global Preventive Medicine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Preventive Medicine Market, By Service Type, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Screening & Early Detection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Vaccination & Immunization
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Preventive Drug Therapies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Wellness & Lifestyle Interventions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Digital Health & Remote Monitoring Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Preventive Medicine Market, By Disease Area, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Respiratory Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Mental Health
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Neurological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Osteoporosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Preventive Medicine Market, By Age Group, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Preventive Medicine Market, By Mode of Delivery, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• On-site/In-Person Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Remote/Virtual Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Preventive Medicine Market, By End User, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Government Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Private Healthcare Providers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Employers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Individuals (Self-Care)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

9. Global Preventive Medicine Market, By Region, 2021 - 2033, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Disease Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Mode of Delivery, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company (BD)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bristol Myers Squibb
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline (GSK)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche Holding AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us